OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction
Ali A. Rabaan, Hajir AlSaihati, Rehab Bukhamsin, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 1954-1976
Open Access | Times Cited: 24
Ali A. Rabaan, Hajir AlSaihati, Rehab Bukhamsin, et al.
Current Oncology (2023) Vol. 30, Iss. 2, pp. 1954-1976
Open Access | Times Cited: 24
Showing 24 citing articles:
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Could Drug Delivery Systems Be Enhancers for Therapy against KRAS-driven Cancers?
Ramil Khusnutdinov
Reviews and Advances in Chemistry (2025)
Closed Access
Ramil Khusnutdinov
Reviews and Advances in Chemistry (2025)
Closed Access
Advances in Cancer Gene Therapy: Strategies, Delivery Methods, and Challenges
Anni Lepland, Kadi-Liis Veiman
Methods in pharmacology and toxicology (2025), pp. 105-123
Closed Access
Anni Lepland, Kadi-Liis Veiman
Methods in pharmacology and toxicology (2025), pp. 105-123
Closed Access
Exosome-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy
Bhavanisha Rithiga S, Rajib Dhar, Arikketh Devi
Gene (2025), pp. 149296-149296
Closed Access
Bhavanisha Rithiga S, Rajib Dhar, Arikketh Devi
Gene (2025), pp. 149296-149296
Closed Access
Genetic advancements in breast cancer treatment: a review
Marzieh Shokoohi, Sadaf Sedaghatshoar, Homaira Arian, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Marzieh Shokoohi, Sadaf Sedaghatshoar, Homaira Arian, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects
Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 4
Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 4
CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications.
Sahar Ebrahimi, Mohammad Khosravi, Abbasali Raz, et al.
PubMed (2023) Vol. 27, Iss. 5, pp. 219-46
Closed Access | Times Cited: 8
Sahar Ebrahimi, Mohammad Khosravi, Abbasali Raz, et al.
PubMed (2023) Vol. 27, Iss. 5, pp. 219-46
Closed Access | Times Cited: 8
Cancer Stem Cell Metastatic Checkpoints and Glycosylation Patterns: Implications for Therapeutic Strategies
Sara Sadat Aghamiri, Rada Amin
Kinases and Phosphatases (2024) Vol. 2, Iss. 2, pp. 151-165
Open Access | Times Cited: 2
Sara Sadat Aghamiri, Rada Amin
Kinases and Phosphatases (2024) Vol. 2, Iss. 2, pp. 151-165
Open Access | Times Cited: 2
Recent Progress in Prompt Molecular Detection of Exosomes Using CRISPR/Cas and Microfluidic‐Assisted Approaches Toward Smart Cancer Diagnosis and Analysis
Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Masoomeh Yari Kalashgrani, et al.
ChemMedChem (2023) Vol. 19, Iss. 1
Closed Access | Times Cited: 6
Seyyed Mojtaba Mousavi, Seyyed Alireza Hashemi, Masoomeh Yari Kalashgrani, et al.
ChemMedChem (2023) Vol. 19, Iss. 1
Closed Access | Times Cited: 6
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways
Atefe Rahmati, Alireza Mafi, Omid Vakili, et al.
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1455-1482
Closed Access | Times Cited: 5
Atefe Rahmati, Alireza Mafi, Omid Vakili, et al.
Annals of Hematology (2023) Vol. 103, Iss. 5, pp. 1455-1482
Closed Access | Times Cited: 5
Epigenetic contribution to cancer
Songhua Quan, Hao Huang
International review of cell and molecular biology (2024), pp. 1-25
Closed Access | Times Cited: 1
Songhua Quan, Hao Huang
International review of cell and molecular biology (2024), pp. 1-25
Closed Access | Times Cited: 1
Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders
Saeed Zanganeh, Amir Mohammad Zahedi, Mahla Sattarzadeh Bardsiri, et al.
Gene (2024) Vol. 931, pp. 148865-148865
Closed Access | Times Cited: 1
Saeed Zanganeh, Amir Mohammad Zahedi, Mahla Sattarzadeh Bardsiri, et al.
Gene (2024) Vol. 931, pp. 148865-148865
Closed Access | Times Cited: 1
Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview
Pankaj Garg, G. D. Singhal, Siddhika Pareek, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189233-189233
Open Access | Times Cited: 1
Pankaj Garg, G. D. Singhal, Siddhika Pareek, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189233-189233
Open Access | Times Cited: 1
Shedding light on the dark genome: Insights into the genetic, CRISPR-based, and pharmacological dependencies of human cancers and disease aggressiveness
Doris Kafita, Panji Nkhoma, Kevin Dzobo, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0296029-e0296029
Open Access | Times Cited: 3
Doris Kafita, Panji Nkhoma, Kevin Dzobo, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0296029-e0296029
Open Access | Times Cited: 3
Shedding Light on the Dark Genome: Insights into the Genetic, CRISPR-based, and Pharmacological Dependencies of Human Cancers and Disease Aggressiveness
Doris Kafita, Panji Nkhoma, Kevin Dzobo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Doris Kafita, Panji Nkhoma, Kevin Dzobo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications
Sahar Ebrahimi, Mohammad Ali Khosravi, Abbasali Raz, et al.
Deleted Journal (2023) Vol. 27, Iss. 5, pp. 219-246
Open Access | Times Cited: 2
Sahar Ebrahimi, Mohammad Ali Khosravi, Abbasali Raz, et al.
Deleted Journal (2023) Vol. 27, Iss. 5, pp. 219-246
Open Access | Times Cited: 2
The Applications of Genome Editing in the Management of Cancer: A Narrative Overview
Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 1, pp. 76-85
Open Access
Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 1, pp. 76-85
Open Access
Precision Gene Editing Strategies with CRISPR-Cas9 for Advancing Cancer Immunotherapy and Alzheimer's Disease
Priyanka Gupte, Karan Dhingra, Saloni
Journal of Knowledge Learning and Science Technology ISSN 2959-6386 (online) (2024) Vol. 3, Iss. 4, pp. 11-21
Open Access
Priyanka Gupte, Karan Dhingra, Saloni
Journal of Knowledge Learning and Science Technology ISSN 2959-6386 (online) (2024) Vol. 3, Iss. 4, pp. 11-21
Open Access
The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer
Antea Kršek, Lara Batičić, Tamara Braut, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 925-925
Open Access
Antea Kršek, Lara Batičić, Tamara Braut, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 925-925
Open Access
The future of neuro-oncology: precision medicine and targeted therapies
Aiman Waheed, Sanan Rasheed, Muhammad Usama, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access
Aiman Waheed, Sanan Rasheed, Muhammad Usama, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access
Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies
Ziyao Lu, Shahab Haghollahi, Muhammad Zubair Afzal
Cancers (2024) Vol. 16, Iss. 20, pp. 3474-3474
Open Access
Ziyao Lu, Shahab Haghollahi, Muhammad Zubair Afzal
Cancers (2024) Vol. 16, Iss. 20, pp. 3474-3474
Open Access
Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signaling
Mobina Tabibian, Fahimeh Salasar Moghaddam, Elahe Motevaseli, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Mobina Tabibian, Fahimeh Salasar Moghaddam, Elahe Motevaseli, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
CRISPR-mediated silencing of non-coding RNAs: a novel putative treatment for prostate cancer
Mobina Tabibian, Soudeh Ghafouri‐Fard
Pathology - Research and Practice (2024) Vol. 264, pp. 155710-155710
Closed Access
Mobina Tabibian, Soudeh Ghafouri‐Fard
Pathology - Research and Practice (2024) Vol. 264, pp. 155710-155710
Closed Access
Diagnostics and Therapy for Malignant Tumors
Chih‐Yang Tsai, Chunyu Wang, Hasok Chang, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2659-2659
Open Access
Chih‐Yang Tsai, Chunyu Wang, Hasok Chang, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2659-2659
Open Access
